Action Trevi Therapeutics - TRVI

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

3,99

Prix Achat

3,80

Prix Vente

4,00

Volume échangé

508 614

3,73 Fourchette du Jour 4,025

1,30 Plage de 52 semaines 4,68

Cap du marché

306,694M

Clôture Veille

3,78

Ouverture

3,77

Dernière Transaction

2730

3.99

(average)

Dernière heure de transaction

Volume financier

US$ 1 965 087

VWAP

3,8636

Volume moyen (3 m)

1 879 268

Actions en circulation

76 865 711

Rendement du Dividende

Ratio Cours sur Bénéfices

-10,53

Bénéfice par action (BPA)

-0,38

Chiffre d'affairess

Bénéfice net

-29,07M

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with... Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, or IPF, and levodopa-induced dyskinesia, or LID, in patients with Parkinson's disease. Show more

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.trevitherapeutics.com

Siège social

Wilmington, Delaware, USA

Fondé

Trevi Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker TRVI. Le dernier cours de clôture d'Trevi Therapeutics était de US$3,78. Au cours de la dernière année, les actions de Trevi Therapeutics ont été négociées dans une fourchette de prix de US$ 1,30 à US$ 4,68.

Trevi Therapeutics compte actuellement 76 865 711 actions en circulation. La capitalisation boursière d'Trevi Therapeutics est de US$290,55 million. Trevi Therapeutics a un ratio cours/bénéfice (ratio PE) de -10.53.

Flux global

Haussier

Prime nette

25k

Calls / Puts

100,00%

Ach. / Vent.

100,00%

OTM / ITM

100,00%

Sweeps Ratio

0,00%

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Trevi Therapeutics Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference

Trevi Therapeutics Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference PR Newswire NEW HAVEN, Conn., Jan. 8...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.18	4.72440944882	3.81	3.99	3.4715	393643	3.7053954	CS
4	-0.05	-1.23762376238	4.04	4.68	3.4715	555502	4.08326738	CS
12	0.95	31.25	3.04	4.68	2.36	1879268	3.60426209	CS
26	1.18	41.9928825623	2.81	4.68	2.36	1013285	3.5258552	CS
52	2.68	204.580152672	1.31	4.68	1.3	633844	3.37848033	CS
156	3.3233	498.470076496	0.6667	4.6834	0.46	543355	2.68773159	CS
260	-0.97	-19.5564516129	4.96	8.5	0.46	377502	2.62623207	CS

TRVI - Frequently Asked Questions (FAQ)

What is the current Trevi Therapeutics share price?

The current share price of Trevi Therapeutics is US$ 3,99

How many Trevi Therapeutics shares are in issue?

Trevi Therapeutics has 76 865 711 shares in issue

What is the market cap of Trevi Therapeutics?

The market capitalisation of Trevi Therapeutics is USD 290,55M

What is the 1 year trading range for Trevi Therapeutics share price?

Trevi Therapeutics has traded in the range of US$ 1,30 to US$ 4,68 during the past year

What is the PE ratio of Trevi Therapeutics?

The price to earnings ratio of Trevi Therapeutics is -10,53

What is the reporting currency for Trevi Therapeutics?

Trevi Therapeutics reports financial results in USD

What is the latest annual profit for Trevi Therapeutics?

The latest annual profit of Trevi Therapeutics is USD -29,07M

What is the registered address of Trevi Therapeutics?

The registered address for Trevi Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Trevi Therapeutics website address?

The website address for Trevi Therapeutics is www.trevitherapeutics.com

Which industry sector does Trevi Therapeutics operate in?

Trevi Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
DWTXDogwood Therapeutics Inc	US$ 13,2484 (373,16%)	103,21M
DGNXDiginex Ltd	US$ 12,75 (70,00%)	9,74M
RNAZTransCode Therapeutics Inc	US$ 5,61 (60,74%)	10,9M
EVAXEvaxion Biotech AS	US$ 3,76 (57,98%)	4,02M
MCTRCTRL Group Ltd	US$ 6,77 (56,35%)	8,84M
CHSNChanson International Holding	US$ 0,83352 (-86,77%)	21,85M
ICONIcon Energy Corporation	US$ 0,5348 (-59,18%)	15,88M
JUNSJupiter Neurosciences Inc	US$ 1,50 (-58,10%)	11,08M
BACKIMAC Holdings Inc	US$ 0,78 (-42,01%)	479,52k
DXSTDecent Holding Inc	US$ 2,50 (-38,42%)	11,55M
HEPAHepion Pharmaceuticals Inc	US$ 0,203 (50,37%)	538,53M
NVDANVIDIA Corporation	US$ 147,22 (0,10%)	155,52M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0,33095 (3,75%)	153,25M
RIMEAlgorhythm Holdings Inc	US$ 0,0338 (1,81%)	137,6M
RGTIRigetti Computing Inc	US$ 13,465 (-3,20%)	133,14M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Trevi Therapeutics Inc (TRVI) Cours

Trevi Therapeutics Inc (TRVI)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Trevi Therapeutics Inc

Flux d'options Trevi Therapeutics (TRVI)

Flux global

Haussier

Prime nette

25k

Calls / Puts

100,00%

Ach. / Vent.

100,00%

OTM / ITM

100,00%

Sweeps Ratio

0,00%

TRVI Dernières nouvelles

TRVI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application